PDB Short entry for 1JVR HEADER MATRIX PROTEIN 03-OCT-96 1JVR TITLE STRUCTURE OF THE HTLV-II MATRIX PROTEIN, NMR, 20 STRUCTURES COMPND MOL_ID: 1; COMPND 2 MOLECULE: HUMAN T-CELL LEUKEMIA VIRUS TYPE II MATRIX PROTEIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HTLV-II MA, MA; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN T-LYMPHOTROPIC VIRUS 2; SOURCE 3 ORGANISM_TAXID: 11909; SOURCE 4 CELL_LINE: BL21; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 8 EXPRESSION_SYSTEM_PLASMID: WISP92-18 KEYWDS HUMAN T-CELL LEUKEMIA VIRUS TYPE II MATRIX PROTEIN, HTLV-II MATRIX KEYWDS 2 PROTEIN, HTLV-II MA, RETROVIRAL MATRIX PROTEIN, P17, MATRIX PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR A.M.CHRISTENSEN,M.A.MASSIAH,B.G.TURNER,W.I.SUNDQUIST,M.F.SUMMERS REVDAT 3 23-FEB-22 1JVR 1 REMARK SEQADV REVDAT 2 24-FEB-09 1JVR 1 VERSN REVDAT 1 12-MAR-97 1JVR 0 JRNL AUTH A.M.CHRISTENSEN,M.A.MASSIAH,B.G.TURNER,W.I.SUNDQUIST, JRNL AUTH 2 M.F.SUMMERS JRNL TITL THREE-DIMENSIONAL STRUCTURE OF THE HTLV-II MATRIX PROTEIN JRNL TITL 2 AND COMPARATIVE ANALYSIS OF MATRIX PROTEINS FROM THE JRNL TITL 3 DIFFERENT CLASSES OF PATHOGENIC HUMAN RETROVIRUSES. JRNL REF J.MOL.BIOL. V. 264 1117 1996 JRNL REFN ISSN 0022-2836 JRNL PMID 9000634 JRNL DOI 10.1006/JMBI.1996.0700 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : DIANA REMARK 3 AUTHORS : GUNTERT,BRAUN,WUTHRICH REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1JVR COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000174378. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 308 REMARK 210 PH : 5.5 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NULL REMARK 210 SPECTROMETER FIELD STRENGTH : NULL REMARK 210 SPECTROMETER MODEL : NULL REMARK 210 SPECTROMETER MANUFACTURER : NULL REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : NULL REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : NULL REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 DBREF 1JVR A 1 136 UNP P03346 GAG_HTLV2 1 136 SEQADV 1JVR GLY A 37 UNP P03346 ARG 37 CONFLICT SEQRES 1 A 137 HIS MET GLY GLN ILE HIS GLY LEU SER PRO THR PRO ILE SEQRES 2 A 137 PRO LYS ALA PRO ARG GLY LEU SER THR HIS HIS TRP LEU SEQRES 3 A 137 ASN PHE LEU GLN ALA ALA TYR ARG LEU GLN PRO GLY PRO SEQRES 4 A 137 SER ASP PHE ASP PHE GLN GLN LEU ARG ARG PHE LEU LYS SEQRES 5 A 137 LEU ALA LEU LYS THR PRO ILE TRP LEU ASN PRO ILE ASP SEQRES 6 A 137 TYR SER LEU LEU ALA SER LEU ILE PRO LYS GLY TYR PRO SEQRES 7 A 137 GLY ARG VAL VAL GLU ILE ILE ASN ILE LEU VAL LYS ASN SEQRES 8 A 137 GLN VAL SER PRO SER ALA PRO ALA ALA PRO VAL PRO THR SEQRES 9 A 137 PRO ILE CYS PRO THR THR THR PRO PRO PRO PRO PRO PRO SEQRES 10 A 137 PRO SER PRO GLU ALA HIS VAL PRO PRO PRO TYR VAL GLU SEQRES 11 A 137 PRO THR THR THR GLN CYS PHE HELIX 1 1 SER A 20 LEU A 34 1 15 HELIX 2 2 PHE A 41 THR A 56 1 16 HELIX 3 3 PRO A 57 ASN A 61 5 5 HELIX 4 4 TYR A 65 ILE A 72 1 8 HELIX 5 5 ARG A 79 SER A 93 1 15 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000